Search clinical trials for: Oshadi Icp

Total 2022 results

Oshadi Drug Administration

Completed

Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study

Diabetes Mellitus, Insulin-Dependent, 1

Israel
Oshadi Drug Administration

Completed

Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study

Diabetes Mellitus | Insulin-Dependent | Type 1

Israel
Oshadi Drug Administration

Completed

Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study

BCC

Israel
Oshadi Drug Administration

Completed

Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment

Cancer | Metastasis | Tumor

Israel
Oshadi Drug Administration

Suspended

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

Mesothelioma

Israel
Oshadi Drug Administration

Completed

Evaluation of the Influence of Food Regimen on Oshadi D Absorption

Lupus Erythematosus, Systemic

Israel
Abant Izzet Baysal University

Completed

Investigation of the Effect of Specially Designed Insoles for Flat-footed Patients

Flat Foot [Pes Planus] (Acquired), Unspecified Foot

Turkey
Oshadi Drug Administration

Unknown

Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Israel
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
University of Michigan
Medical University of South Carolina; University of Pennsylvania; National Institute... and other collaborators

Recruiting

Brain Oxygen Optimization in Severe TBI, Phase 3 (BOOST3)

Brain Injuries, Traumatic

United States, Canada
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (ICC)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations

Advanced Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-022 in Patients With R/R DLBCL (DLBCL)

Diffuse Large B Cell Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Clinical Study of ICP-192 in Solid Tumors Patients

Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory

China
Assiut University

Unknown

Intracranial Pressure Monitoring in Sever Traumatic Brain Injury Single Center Experience

Head Injury Trauma
Boston Scientific Corporation

Active, not recruiting

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP)

Tachycardia, Ventricular | Arrhythmia, Ventricular

United States, Spain, Italy, United Kingdom, Netherlands, France, Czechia, Austria, Canada
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Phase 2 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors

Advanced Solid Tumors Harboring NTRK Fusion | Primary Central Nervous System Tumors Harboring NTRK Fusion

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

Solid Tumors

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)

MZL

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)

Mantle Cell Lymphoma

China
InnoCare Pharma Inc.

Active, not recruiting

Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
InnoCare Pharma Inc.

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 in Mature B-cell Malignancies

Mature B-cell Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

The Study of ICP-248 in Patients With Mature B-cell Malignancies

Hematological Malignancies

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Bladder Urothelial Cancer

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

PCNSL | Secondary Central Nervous System Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

A Study to Evaluate ICP-022 in Patients With CLL/ SLL

CLL/SLL

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

Study of ICP-105 in Solid Tumors Patients

Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Cholangiocarcinoma | Urothelial Carcinoma

Australia, United States
Medical University of Vienna

Completed

Intracranial Pressure (ICP) Monitoring Following Traumatic Brain Injury (TBI)

Traumatic Brain Injury

Austria
Holland Bloorview Kids Rehabilitation Hospital

Completed

Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy

Cerebral Palsy

Canada
Innocare Pharma Australia Pty Ltd

Completed

A Phase I Study of ICP-022 in Healthy Subjects

Rheumatoid Arthritis | Systemic Lupus Erythematosus

Australia
Javier Fandino, MD
Kaunas University of Technology

Completed

Non-invasive Brain Pressure Monitoring After Trauma or Hemorrhage

Traumatic Brain Injury (TBI) | Subarachnoid Hemorrhage (SAH)

Switzerland
Zagazig University

Recruiting

Multifidus Cervicis and Inter-Semispinal Plane Blocks in Analgesia After Cervical Spine Surgery

Cervical Spine Surgery

Egypt
Shandong University

Not yet recruiting

A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Immune Thrombocytopenia | Bruton's Tyrosine Kinase
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

ADME Study of [14C]ICP-022 in Healthy Males

Healthy Volunteers

China
Beijing InnoCare Pharma Tech Co., Ltd.

Not yet recruiting

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematologic Malignancies

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis

Psoriasis

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-033 in Patients With Advanced Solid Tumors

Patients With Advanced Solid Tumors

China
Oculogica, Inc.

Completed

Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

Intracranial Pressure Increase

United States
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy Subjects

Healthy Subjects

China
Boston Neurosciences

Unknown

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Intracranial Hypertension | Abnormality of Intracranial Pressure

United States
Oshadi Drug Administration

Completed

Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients

Diabetes

Israel
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

China
Oslo University Hospital

Completed

ICP Versus Intracranial Compliance Guided Management in SAH

Subarachnoid Hemorrhage (SAH)

Norway
University of Pennsylvania
University of Miami; National Institute of Neurological Disorders and Stroke... and other collaborators

Completed

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI) (BOOST 2)

Severe Traumatic Brain Injury

United States
Beijing InnoCare Pharma Tech Co., Ltd.

Not yet recruiting

A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Patients With Advanced Solid Tumors

China
Kantonsspital Aarau

Unknown

aICP in Glaucoma and Papilledema (aICP Ophtha)

Open-angle Glaucoma | Papilledema

Switzerland
Children's Healthcare of Atlanta
Geogia Trauma Foundation

Enrolling by invitation

Intraoperative Monitoring of Femoral Head Perfusion

Femoral Neck Fractures

United States

Search clinical trials for: Oshadi Icp

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations